Could a Triple-Drug attack before surgery eliminate more breast cancer in older women?
Disease control
Recruiting now
This study tests whether adding the drug olaparib to standard trastuzumab and pertuzumab before surgery can improve outcomes for women aged 60 and older with HER2-positive breast cancer. Participants receive the combination for up to six cycles before surgery, and doctors check h…
Phase: PHASE4 • Sponsor: Wen-Ming Cao • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC